Willkommen bei Valicare!
-
Unsere Experten bieten GMP-Beratung, Konzeptionierung und Unterstützung vor Ort!
Rufen Sie an: +49 69 153 293 701
Mehr erfahren -
Unsere Experten bieten GMP-Beratung, Konzeptionierung und Unterstützung vor Ort!
Rufen Sie an: +49 69 153 293 701
Mehr erfahren
Events
-
11 Mai 202114 Mai 2021Wien / Österreich PBP World Meeting 12. Welttreffen über Pharmazeutik, Biopharmazie und pharmazeutische Technologie
-
20 Sep 202121 Sep 2021Stuttgart / Deutschland Deutsche Biotechnologie-Tage Deutschlands größtes Biotech-Event, die Deutschen Biotechnologietage 2021, das Forum für den Erfahrungsaustausch zwischen allen Akteuren der deutschen Biotechnologieszene, finden vom 20.- 21. September 2021 in Stuttgart statt.
-
05 Okt 202106 Okt 2021Frankfurt am Main / Deutschland 2nd APV Interactive Workshop on ATMP Am 05. und 06. Oktober 2021 wird der zweite APV Experten-Workshop diesmal zum Thema “Bridging standard pharma concepts and ATMP” stattfinden.
Nachrichten aus aller Welt
Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).
The Tissue Origin Effect of Extracellular Vesicles on Cartilage and Bone Regeneration
28.02.2021 | Science DirectAbstract Direct implantation of mesenchymal stem cells (MSCs) for cartilage and bone tissue engineering faces challenges, such as immune ...
Efficient in vivo genome editing mediated by stem cells-derived extracellular vesicles carrying designer nucleases
26.02.2021 | bioRxivPrecise genome editing using designer nucleases (DNs), such as zinc finger nucleases (ZFNs), transcription activator-like effector ...
Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis
26.02.2021 | NatureAbstract Background Recent studies have shown that obesity is associated with the severity of coronavirus disease (COVID-19). We reviewed ...
Novel CAR-T Cell Therapy Produces Sustainable Response in Patients with Relapsed Multiple Myeloma
26.02.2021 | CURETreatment with the chimeric antigen receptor (CAR)-T cell therapy idecabtagene vicleucel (ide-cel) induced deep, sustained remissions in ...
PharmaShots Weekly Snapshots (Feb 22- 26, 2021)
26.02.2021 | PharmaShotsRegeneron Reports IDMC Clearance of Efficacy for REGEN-COV (Casirivimab + Imdevimab) in P-III COVID-19 Outpatient Outcomes Trial
Celonic to Boost its Cell & Gene Therapy Production with Facility in the Upcoming Lif...
25.02.2021 | BioPharmAnalysesCelonic, a leading global CDMO, specialized in development and production of Advanced Therapy Medicinal Products (ATMP) and bio- ...
Orna Therapeutics launches with $80 million for circular mRNA therapies
25.02.2021 | Chemical & Engineering NewsThe MIT spin-off says circularized mRNA therapies could be cheaper and more effective than linear mRNA
Perspectives on Oncolytic Salmonella in Cancer Immunotherapy—A Promising Strategy
25.02.2021 | FrontiersSince the first reported spontaneous regression of tumors in patients with streptococcus infection, cancer biological therapy was born and ...
2020 clinical trials database report confirms UK globally attractive clinical space to develop cell and gene therapies
25.02.2021 | Pharmabiz.comThe Cell and Gene Therapy Catapult (CGT Catapult), an independent centre of excellence to advance the growth of the UK cell and gene ...
Ocugen’s inherited retinal disease gene therapy OCU400 wins orphan status
24.02.2021 | PharmaTimesThe European Commission (EC) has granted Ocugen’s gene therapy candidate OCU400 an orphan medicinal product designation for the treatment ...
Bristol Myers, hot off Breyanzi nod, plots new cell therapy factory in Massachusetts
23.02.2021 | FiercePharmaBristol Myers Squibb, freshly armed with an approval for its CAR-T med Breyanzi, is making a major cell therapy manufacturing play. The ...
European Cancer Deals Increasingly Focus on Natural Killer Cells
23.02.2021 | Labiotech.eu
Clinical Catch-Up: February 15-19
22.02.2021 | Bio SpaceIt was a busy week for clinical trial announcements. Here’s a look. COVID-19-Related All India Institute of Medical Sciences (AIIMS) ...
Zynteglo halt re-ignites viral vector safety concerns; analysts
22.02.2021 | PharmaphorumBluebird Bio’s decision to hit pause on the launch of Zynteglo for beta thalassaemia after two cases of cancer were seen in a clinical ...
Project Farma: Manufacturing Skills Gap Creates Bottleneck for Cell and Gene Therapy
19.02.2021 | Bio SpaceThe skills gap in cell and gene therapy is creating a bottleneck that is slowing the abilities of innovative therapies to reach patients, ...
Valicare – kompetent, zuverlässig & effizient
Sie haben wenig Zeit und möchten trotzdem wissen, welche Dienstleistungen die Valicare GmbH anbietet?